There were insignificant differences in serum lipocalin between mild eczema (median: 83.0 ng/mL; min–max: 55.6–147.2 ng/mL), severe eczema patients (median: 87.8 ng/mL; min–max: 56.0–147.6 ng/mL), and healthy controls (median: 96.7 ng/mL; min–max: 52.6–178.3 ng/mL) (p = 0.714), other than the afore-mentioned association between lipocalin-2 and resistin levels. The gene discussed is RETN; the disease is Eczematoid dermatitis.